Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

04/03/18GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
04/03/18GBT Announces New Employment Inducement Grants
03/15/18GBT Announces New Employment Inducement Grants
03/12/18Global Blood Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares

More »

Media Resources

Stay Informed

Sign up to receive email updates about ongoing sickle cell disease clinical studies, awareness and educational information and GBT news at:

Media Contact

Julie Normart